Article Sidebar

PDF
Date Published: 05/01/2022
Abstract Views: 765
Views PDF: 554
DOI: https://doi.org/10.51298/vmj.v508i1.1512
Issue
Vol. 508 No. 1 (2021)
Section
Các bài báo
How to Cite
Thị Thu Hương, P. ., Văn Thường, N. ., & Hồng Khôi, V. . (2022). ASSESSMENT OF TREATMENT EFFECT OF POST-HERPETIC NEURALGIA WITH LIDOCAINE PATCH 5% IN COMBINATION WITH PREGABALIN AT NATIONAL HOSPITAL OF DERMATOLOGY AND VENEREOLOGY. Vietnam Medical Journal, 508(1). https://doi.org/10.51298/vmj.v508i1.1512

ASSESSMENT OF TREATMENT EFFECT OF POST-HERPETIC NEURALGIA WITH LIDOCAINE PATCH 5% IN COMBINATION WITH PREGABALIN AT NATIONAL HOSPITAL OF DERMATOLOGY AND VENEREOLOGY

Phạm Thị Thu Hương1,, Nguyễn Văn Thường1,2, Võ Hồng Khôi3
1 Hanoi Medical University
2 National Hospital of Dermatology and Venereology
3 Bach Mai Hospital

Main Article Content

Abstract

Objective: To assess of treatment effect of post-herpetic neuralgia with lidocaine patch 5% in combination with pregabalin at National Hospital of Dermatology and Venereology. Subjects and methods: Clinical research, randomized controlled trials (RCTs) of 120 patients with post-herpetic neuralgia at National Hospital of Dermatology and Venereology from July 2020 to May 2021.Results: Mean age of research and control group were 66.43 ± 8.67 and 66,57 ± 8,66, repecstively. After 8 weeks, NRS score did not show difference between two groups, average NRS score was 0.68. After two weeks, 41.7% of the patients in the study group has significant pain relief in compared with only 1.7% of the control group. After 8 weeks, 75% of the study group had complete pain relief in compared with 64.7% of the control group. Dry mouth was the most common side effect in both study and control group  with the ratio were 96.7% and 93.3%, repectivesly.

Article Details

Keywords

Post-herpetic neuralgia, lidocaine patch 5%, Pregabalin

References

1. Johnson RW, Dworkin RH. Treatment of herpes zoster and postherpetic neuralgia. Bmj. 2003;326(7392):748-750.
2. Yawn BP, Saddier P, Wollan PC, Sauver JLS, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Elsevier; 2007:1341-1349.
3. Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ open. 2014;4(6):e004833.
4. Marra F, Parhar K, Huang B, Vadlamudi N. Risk factors for herpes zoster infection: a meta-analysis. Oxford University Press US; 2020:ofaa005.
5. Wolff RF, Bala M, Westwood M, Kessels A, Kleijnen J. 5% lidocaine‐medicated plaster vs other relevant interventions and placebo for post‐herpetic neuralgia (PHN): a systematic review. Acta neurologica Scandinavica. 2011;123 (5):295-309.